We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Immunochromatographic Test Evaluated to Diagnose Schistosomiasis

By LabMedica International staff writers
Posted on 02 Feb 2016
Print article
Image: The circulating cathodic antigen immunochromatographic test of two patient’s urine for Schistosoma mansoni (Photo courtesy of Saarland University).
Image: The circulating cathodic antigen immunochromatographic test of two patient’s urine for Schistosoma mansoni (Photo courtesy of Saarland University).
The Kato-Katz (KK) stool smear is the standard test for the diagnosis of Schistosoma mansoni infection but suffers from low sensitivity when infections intensities are moderate to low and therefore, misdiagnosed individuals remain untreated and contribute to the disease transmission.

As an alternative, the urine-based diagnosis of schistosomiasis mansoni via the circulating cathodic antigen immuno-chromatographic test (CCA-ICT) has been extensively evaluated in Africa with the conclusion that it may replace the KK test in areas where the prevalence is moderate or high.

Scientists at the University Vale do Rio Doce (Governador Valadares, Brazil) and their colleagues measured the performance of the CCA-ICT in a sample study population composed of residents from non-endemic and endemic areas for schistosomiasis in two municipalities of Minas Gerais state (Brazil). Volunteers were classified into three infection status groups based on duplicate Kato-Katz thick smears from one stool sample (2KK test): 41 negative individuals from non-endemic areas, 41 negative individuals from endemic areas and 48 infected individuals from endemic areas.

The rapid immuno-chromatographic test used was the commercially available Bilharzia RDT (Rapid Medical Diagnostics; Pretoria, Republic of South Africa), which measures a parasite-derived “circulating cathodic antigen (CCA)” in the urine of patients infected with S. mansoni. Infection status was also determined by the CCA-ICT and infection exposure by antibody enzyme-linked immunosorbent assay (ELISA) to S. mansoni soluble egg antigen (SEA) and soluble (adult) worm antigen preparation (SWAP).

The investigators found that sensitivity and specificity were influenced by whether the trace score visually adjudicated in the CCA-ICT was characterized as positive or negative for S. mansoni infection. When the trace score was interpreted as a positive rather than as a negative result, the specificity decreased from 97.6% to 78.0% whereas sensitivity increased from 68.7% to 85.4%. A significantly positive correlation between the CCA-ICT scores and egg counts was identified. Considering 2KK as reference test, the discriminating power of the CCA-ICT was greater than the SEA-ELISA and SWAP-ELISA.

The authors concluded that the performance of the CCA-ICT in the Brazilian communities endemic for schistosomiasis mansoni support those from Africa in areas with greater infection prevalence and intensities, the CCA-ICT may be useful as a tool to indicate community-based preventative chemotherapy without individual diagnosis. However, because of the Brazilian Ministry of Health’s recommendation for individual diagnosis in areas where prevalence is less than 15%, in those areas in which infection intensities are likely to be lowest, the CCA-ICT lacks the sensitivity to be used as standalone diagnostic tool. The study was published on January 11, 2016, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

University Vale do Rio Doce 
Rapid Medical Diagnostics


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Pathology

view channel
Image: Fingertip blood sample collection on the Babson Handwarmer (Photo courtesy of Babson Diagnostics)

Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection

Warming the hand is an effective way to facilitate blood collection from a fingertip, yet off-the-shelf solutions often do not fulfill laboratory requirements. Now, a unique hand-warming technology has... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.